FTC Wants Access To Boehringer Docs In Pay-For-Delay Probe
The Federal Trade Commission told the D.C. Circuit on Wednesday that it should force Boehringer Ingelheim Pharmaceuticals Inc. to turn over documents about a $100 million drug co-promotion deal with Barr...To view the full article, register now.
Already a subscriber? Click here to view full article